Headline after headline has been written about a 2024 study, published in the scientific journal Biomolecules, which suggests ...

In the early days of human history — over 300,000 years ago — Homo sapiens shared the Earth with several other human species, ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...

Brain injury resulting from hypoxia (oxygen deprivation) or ischemia (restricted blood flow) represents a major challenge in medical research and clinical ...

RBC Capital analyst Brian Abrahams maintained a Buy rating on BioCryst (BCRX – Research Report) on January 21 and set a price target of $10.00.

The guidelines support use of PPIs, dietary therapy, and biologics for EoE, and stress the importance of addressing both the ...

Son of sevenless homolog 1 (SOS1) is an essential guanine nucleotide exchange factor (GEF) in KRAS-driven tumors, and it also functions as a downstream node protein of BCR-ABL, suggesting its critical ...

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...

Gastric cancer remains a critical public health issue globally, with new statistics from the National Cancer Center indicating about 514,000 new cases in ...

A recent study published in Nature examined the infection dynamics and pathological outcomes associated with the highly pathogenic avian influenza (HPAI) H5N1 virus, specifically the clade 2.3.4.4b ...

Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, ...